Skip to main content
Equibles

UBS Group AG

Position in LITS — Lite Strategy, Inc.

CIK 1610520 ZURICH, V8
Back to LITS Full portfolio

Position in LITS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$83,849
+$24,284 QoQ
Shares Held
91,141
+77.5% QoQ
Ownership
0.300%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 35 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LITS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,672,124 across 561 Biotechnology names. LITS ranks #369 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in LITS

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $83,849 91,141
2026-03-31 $59,565 51,350
2025-12-31 $165,063 125,048
2025-09-30 $1,929,024 797,118
2025-06-30 $20,382 8,252
2025-03-31 $14,113 6,445
2024-12-31 $27,455 11,161
2024-09-30 $36,701 12,878
2024-06-30 $23,570 8,100
2024-03-31 $17,192 4,298
2023-12-31 $3,403 587
2023-09-30 $112 16
2023-06-30 $105 16